The impact of TSC-1 and -2 mutations on response to therapy in malignant PEComa: A multicenter retrospective analysis

Authors

Lawrence Liu, City of Hope Comprehensive Cancer Center
Nikhil Grandhi, Washington University School of Medicine in St. Louis
Yang Lyu, Washington University School of Medicine in St. Louis
Xiao Zhang, Washington University School of Medicine in St. Louis
Jingqin Luo, Washington University School of Medicine in St. Louis
Mia Weiss, Washington University School of Medicine in St. Louis
Brian Van Tine, Washington University School of Medicine in St. Louis
Angela C Hirbe, Washington University School of Medicine in St. Louis
et al.

Journal

Genes

Publication Date

10-24-2022

Volume

13

Issue

11

First Page

1932

Document Type

Open Access Publication

DOI

10.3390/genes13111932

Rights and Permissions

Liu, L.; Dehner, C.; Grandhi, N.; Lyu, Y.; Borcherding, D.C.; Chrisinger, J.S.A.; Zhang, X.; Luo, J.; Tao, Y.; Parkes, A.; Bui, N.Q.; Davis, E.J.; Milhem, M.M.; Monga, V.; Weiss, M.; Tine, B.V.; Hirbe, A.C. The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis. Genes 2022, 13, 1932. https://doi.org/10.3390/genes13111932 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Liu, Lawrence; Grandhi, Nikhil; Lyu, Yang; Zhang, Xiao; Luo, Jingqin; Weiss, Mia; Tine, Brian Van; Hirbe, Angela C; and et al., "The impact of TSC-1 and -2 mutations on response to therapy in malignant PEComa: A multicenter retrospective analysis." Genes. 13, 11. 1932 (2022).
https://digitalcommons.wustl.edu/oa_4/986

Additional Links

Supplemental material is available for this article at publisher site.